Boothbay Fund Management, LLC Relmada Therapeutics, Inc. Transaction History

Boothbay Fund Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.17 - $35.84 $27,758 - $458,465	12,792 New	12,792 $44,000
Q3 2021 Nov 15, 2021	SELL	$21.86 - $34.77 $750,956 - $1.19 Million	-34,353 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$29.55 - $39.15 $33,746 - $44,709	1,142 Added 3.44%	34,353 $1.1 Million
Q1 2021 May 17, 2021	BUY	$31.52 - $39.28 $1.05 Million - $1.3 Million	33,211 New	33,211 $1.17 Million

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $10.9M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.